These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27788764)

  • 1. Haploidentical cord transplantation-The best of both worlds.
    van Besien K; Childs R
    Semin Hematol; 2016 Oct; 53(4):257-266. PubMed ID: 27788764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
    Tsai SB; Liu H; Shore T; Fan Y; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Martinez G; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1065-1072. PubMed ID: 26912055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
    El-Cheikh J; Crocchiolo R; Furst S; Bramanti S; Sarina B; Granata A; Vai A; Lemarie C; Faucher C; Mohty B; Harbi S; Bouabdallah R; Vey N; Santoro A; Chabannon C; Castagna L; Blaise D
    Cancer; 2015 Jun; 121(11):1809-16. PubMed ID: 25649994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cord blood chimerism and relapse after haplo-cord transplantation.
    van Besien K; Koshy N; Gergis U; Mayer S; Cushing M; Rennert H; Reich-Slotky R; Mark T; Pearse R; Rossi A; Phillips A; Vasovic L; Ferrante R; Hsu YM; Shore T
    Leuk Lymphoma; 2017 Feb; 58(2):288-297. PubMed ID: 27333804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
    Kaida K; Ikegame K; Inoue T; Maruyama S; Ishii S; Uchida N; Doki N; Eto T; Fukuda T; Katayama Y; Takada S; Kawakita T; Ichinohe T; Atsuta Y; Daimon T; Ogawa H
    Transplant Cell Ther; 2023 Apr; 29(4):273.e1-273.e9. PubMed ID: 36641032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
    Tsai SB; Rhodes J; Liu H; Shore T; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
    Biol Blood Marrow Transplant; 2018 May; 24(5):997-1004. PubMed ID: 29288821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
    Hsu J; Artz A; Mayer SA; Guarner D; Bishop MR; Reich-Slotky R; Smith SM; Greenberg J; Kline J; Ferrante R; Phillips AA; Gergis U; Liu H; Stock W; Cushing M; Shore TB; van Besien K
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):359-365. PubMed ID: 29128555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Childs RW; Tian X; Vo P; Purev E; Kotecha RR; Carlsten M; Clara J; Flegel WA; Adams SD; Khuu HM; Stroncek DF; Cook L; Worthy T; Geller NL; Wells B; Wilder J; Reger R; Aue G
    Br J Haematol; 2021 Jun; 193(5):951-960. PubMed ID: 33993466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
    Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO
    Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Cord Blood Transplantation Versus HLA-Haploidentical-related Donor Transplantation Using Posttransplant Cyclophosphamide in Patients With Hematological Malignancies.
    Wada F; Kanda J; Yoshioka S; Ishikawa T; Akasaka T; Ueda Y; Hirata H; Arai Y; Yago K; Anzai N; Watanabe M; Ikeda T; Yonezawa A; Imada K; Itoh M; Kitano T; Takeoka T; Hishizawa M; Nohgawa M; Arima N; Asagoe K; Kondo T; Takaori-Kondo A;
    Transplantation; 2022 Jun; 106(6):1279-1287. PubMed ID: 34935764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
    van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
    Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?
    Liu H; van Besien K
    Curr Hematol Malig Rep; 2015 Mar; 10(1):1-7. PubMed ID: 25667129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomes.
    van Besien K; Liu H; Margevicius S; Fu P; Artz A; Chaekal OK; Metheny L; Shore T; Kosuri S; Mayer S; Gomez-Arteaga A; Kwon M
    Leuk Lymphoma; 2024 Oct; 65(10):1384-1397. PubMed ID: 38949786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study.
    Lei M; Zhang Y; Jiao W; Li X; Zhou H; Wang Q; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Miao M; Liu L; Wu D
    Front Immunol; 2022; 13():912917. PubMed ID: 35812409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.
    Sanz J; Montoro J; Solano C; Valcárcel D; Sampol A; Ferrá C; Parody R; Lorenzo I; Montesinos P; Ortí G; Hernández-Boluda JC; Balaguer-Roselló A; Guerreiro M; Carretero C; Sanz GF; Sanz MA; Piñana JL
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):358-366. PubMed ID: 31655119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies.
    Li H; Li X; Chen Y; Li D; Chen X; Zhu Z; Wang Y; Huang J; Chen P; Chen Y; Li N
    Front Immunol; 2021; 12():733326. PubMed ID: 34804017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.
    Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Serrano D; Anguita J; Buño I; Fores R; Regidor C; García Marco JA; Vilches C; de Pablo R; Fernández MN; Gayoso J; Duarte R; Díez-Martín JL; Cabrera R
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2015-22. PubMed ID: 25255162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.